JOSHUA CZARNECKI: Open Payments
NPI 1306472048 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,849 in 59 payments from 14 companies in 2025. Trend: 2023 $925 · 2024 $557 · 2025 $1,849
Food & beverage: $1,849
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $402 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $320 |
| AstraZeneca Pharmaceuticals LP | 3 | $227 |
| Lilly USA, LLC | 10 | $158 |
| GlaxoSmithKline, LLC. | 5 | $153 |
| Novo Nordisk Inc | 2 | $150 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $118 |
| SI-BONE, INC. | 1 | $92 |
| Exact Sciences Corporation | 4 | $72 |
| Amgen Inc. | 4 | $59 |
Products named: VRAYLAR, Kerendia, Ozempic, MOUNJARO, ANNOVERA, AREXVY, AIRSUPRA, OTEZLA.
Industry payments across TX — which companies pay providers there.
